U.S. Premarket: Roivant Surges 24%
Roivant rose 24% after a Phase 2 trial of a pulmonary arterial hypertension drug developed by its subsidiary, while Novartis fell 12% and quantum computing stocks gained on news of investment under the U.S. CHIPS Act.
What are the key facts?
- 1Roivant Sciences shares rose 24%
- 2Novartis shares fell 12%
- 3Boston Scientific shares fell more than 2%
- 4D-Wave shares rose more than 5%
What happened?
Roivant Sciences shares rose 24% in premarket trading. The pharmaceutical company said Phase 2 trial results for mosliciguat, developed by its subsidiary Pulmovant, showed a clinically meaningful and statistically significant reduction in pulmonary vascular resistance versus placebo among patients with pulmonary hypertension associated with interstitial lung disease. Lockheed Martin rose 0.7% after UBS upgraded its rating from neutral to buy. Novartis fell 12% after a Phase 3 trial showed that del-desiran failed to produce significant improvement in patients with type 1 myotonic dystrophy. Peloton Interactive fell more than 4% after Morgan Stanley downgraded the stock to underweight. Boston Scientific fell more than 2% after the company said a recent cyberattack could affect its 2026 sales and profit targets. Bloom Energy rose more than 6% after preparing to join the S&P 500 on Sept. 21. Quantum computing stocks rose after the U.S. announced a $300 million CHIPS Act transaction to acquire minority stakes in several companies, including D-Wave Quantum, Rigetti Computing and Quantinuum.
What does this mean for cross-border sellers?
Roivant’s clinical-trial progress, Novartis’ trial results and Boston Scientific’s cyberattack show how healthcare and technology markets can be affected simultaneously by research outcomes, rating changes and cybersecurity incidents. Sellers should assess demand for products related to healthcare, fitness, quantum computing or AI data centers cautiously and monitor operational risks among suppliers and partners.
What should sellers do now?
- 1Separately flag products in the store related to healthcare, fitness, quantum computing and AI data centers, and review recent orders, searches and conversion data to avoid increasing inventory solely because related stocks have risen or fallen.My AI Agents
- 2Check supplier, ERP and store-backend account permissions, login records and data-backup status this week, prioritizing shared accounts still in use and critical order data that has not been backed up.Market Trends